通脉口服液治疗小儿病毒性心肌炎的临床研究

来源 :中国医药学报 | 被引量 : 0次 | 上传用户:Jianhcn
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
通脉口服液是根据我院陈宝义教授临床经验而研制的纯中药制剂,主治小儿病毒性心肌炎心脉瘀阻证。为了全面系统地观察该药的临床疗效,我院小儿心肌炎专科自1992年起,重点观察了通脉口服液对小儿病毒性心肌炎心脉瘀阻证的疗效,并与西药一般疗法进行对照观察,现报告如下。 Tongmai Oral Liquid is based on the clinical experience of Professor Chen Baoyi hospital developed pure Chinese medicine preparations, attending pediatric viral myocarditis heart stasis card. In order to comprehensively and systematically observe the clinical efficacy of the drug, pediatric myocarditis specialist in our hospital since 1992, focused on the observation Tongmai oral solution of viral myocarditis in children with cardio-vascular stasis syndrome efficacy and western medicine general therapy control observation, The report is as follows.
其他文献